v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' DEFICIT - USD ($)
$ in Thousands
COMMON STOCK
ADDITIONAL PAID-IN CAPITAL
ACCUMULATED DEFICIT
ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)
TREASURY STOCK AT COST
Total
Increase (Decrease) in Temporary Equity [Roll Forward]            
Class A ordinary shares subject to possible redemption           $ 249,652
Redeemable convertible preferred stock (in shares)           18,349,937
Beginning balance at Dec. 31, 2023   $ 16,055 $ (127,387) $ 113 $ (34) $ (111,253)
Beginning balance (in shares) at Dec. 31, 2023 5,006,697          
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance from stock option exercises   13       13
Issuance from stock option exercises (in shares) 9,354          
Stock based compensation   9,125       9,125
Foreign currency translation adjustments       (37)   (37)
Net loss     (54,344)     (54,344)
Ending balance at Dec. 31, 2024   25,193 (181,731) 76 (34) $ (156,496)
Ending balance (in shares) at Dec. 31, 2024 5,016,051         5,016,051
Ending balance at Dec. 31, 2024   25,193 (181,731) 76 (34) $ (156,496)
Ending balance (in shares) at Dec. 31, 2024 5,016,051         5,016,051
Increase (Decrease) in Temporary Equity [Roll Forward]            
Class A ordinary shares subject to possible redemption           $ 249,652
Redeemable convertible preferred stock (in shares)           18,349,937
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance from stock option exercises   2       $ 2
Issuance from stock option exercises (in shares) 300         300
Stock based compensation   3,857       $ 3,857
Foreign currency translation adjustments       8   8
Net loss     (12,870)     (12,870)
Ending balance at Mar. 31, 2025   29,052 (194,601) 84 (34) (165,499)
Ending balance (in shares) at Mar. 31, 2025 5,016,351          
Beginning balance at Dec. 31, 2024   25,193 (181,731) 76 (34) $ (156,496)
Beginning balance (in shares) at Dec. 31, 2024 5,016,051         5,016,051
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance from stock option exercises   19       $ 19
Issuance from stock option exercises (in shares) 5,477         5,477
Issuance from vesting of RSAs (in shares) 17,910          
Stock based compensation   9,449       $ 9,449
Foreign currency translation adjustments       (521)   (521)
Net loss     (73,845)     (73,845)
Ending balance at Dec. 31, 2025   34,661 (255,576) (445) (34) $ (221,394)
Ending balance (in shares) at Dec. 31, 2025 5,039,438         5,039,438
Increase (Decrease) in Temporary Equity [Roll Forward]            
Class A ordinary shares subject to possible redemption           $ 249,652
Redeemable convertible preferred stock (in shares)           18,349,937
Class A ordinary shares subject to possible redemption           $ 249,652
Redeemable convertible preferred stock (in shares)           18,349,937
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance from stock option exercises   90       $ 90
Issuance from stock option exercises (in shares) 29,252         29,252
Stock based compensation   1,534       $ 1,534
Foreign currency translation adjustments       (298)   (298)
Net loss     (8,575)     (8,575)
Ending balance at Mar. 31, 2026   $ 36,285 $ (264,151) $ (743) $ (34) $ (228,643)
Ending balance (in shares) at Mar. 31, 2026 5,068,690         5,068,690
Increase (Decrease) in Temporary Equity [Roll Forward]            
Class A ordinary shares subject to possible redemption           $ 249,652
Redeemable convertible preferred stock (in shares)           18,349,937